Skip to main content

Equillium, Inc.

EQ
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001746466

No open-market purchases or sales by Equillium, Inc. insiders were filed in the last 90 days; 60 institutions reported holding it in 13F filings for Q2 2026, worth $133.0M in total; no superinvestor holds it.

Superinvestors holding EQ, Q2 2026

See all superinvestors

No superinvestor reported holding EQ in Q2 2026.